Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × naxitamab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 14 Sarcoma 1

Conditions

Sarcoma, Ewing 1 Sarcoma 1 Osteosarcoma 1 Neuroblastoma 1

Interventions

Cyclophosphamide 22 Temozolomide 14 Irinotecan 12 Filgrastim 11 Melphalan 10 Etoposide 9 Vincristine 8 Peripheral Blood Stem Cell Transplantation 8 Granulocyte Colony-Stimulating Factor 8 X-Rays 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 Carboplatin 7 fludarabine 6 Topotecan 6 Phantoms, Imaging 6 Busulfan 6 fludarabine phosphate 5 Radiotherapy 5 Biopsy 5 Antilymphocyte Serum 5 Thiotepa 4 Nuclear Medicine Department, Hospital 4 Nivolumab 4 Methylprednisolone 4 Ifosfamide 4 Cisplatin 4 palbociclib 3 etoposide phosphate 3 dinutuximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06438614 2024-08-29

NICE

Fundació Sant Joan de Déu

Phase 2 Completed

Neuroblastoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡